Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Insmed Incorporated - Common Stock (NQ:INSM)

178.20 +0.78 (+0.44%)

Streaming Delayed Price Updated: 11:24 AM EST, Dec 26, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	300,879
Open	178.90
Bid (Size)	177.97 (100)
Ask (Size)	178.38 (100)
Prev. Close	177.42
Today's Range	176.67 - 179.44
52wk Range	60.40 - 212.75
Shares Outstanding	115,246,666
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Insmed Stock Plunges Nearly 20% After Hours As Sinus Drug Fails Mid-Stage Trial And Shows No Benefit ↗

December 17, 2025

While the drug was well tolerated with no new safety concerns, the drug yielded no positive treatment benefits in a study even at its highest dose of 40 mg.

Via Stocktwits

Wondering what's happening in today's after-hours session? ↗

December 17, 2025

As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Performance

YTD	+154.8%	+154.8%
1 Month	-14.7%	-14.7%
3 Month	+31.4%	+31.4%
6 Month	+75.2%	+75.2%
1 Year	+152.2%	+152.2%

More News

Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗

December 03, 2025

Via The Motley Fool

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

A Preview Of Insmed's Earnings ↗

October 29, 2025

Via Benzinga

Analyst Expectations For Insmed's Future ↗

October 02, 2025

Via Benzinga

PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? ↗

December 03, 2025

Via The Motley Fool

Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? ↗

December 03, 2025

Via The Motley Fool

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

Via MarketMinute

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

December 02, 2025

From BioMedWire

Via GlobeNewswire

30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks ↗

November 30, 2025

Via The Motley Fool

Billionaire Stanley Druckenmiller Just Bet Big on This Hot IPO Stock. Is It a Buy? ↗

November 23, 2025

Via The Motley Fool

Peering Into Insmed Inc's Recent Short Interest ↗

November 18, 2025

Via Benzinga

Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗

November 14, 2025

Via Benzinga

If You Invested $1000 In Insmed Stock 10 Years Ago, You Would Have This Much Today ↗

November 14, 2025

Via Benzinga

This Investor Sold $1.9 Million in AMSC Stock Ahead of 35% Post-Earnings Crash ↗

November 10, 2025

Via The Motley Fool

Essex Investment Buys $7.1 Million Globalstar Stake as Revenue Hits Record High ↗

November 09, 2025

Via The Motley Fool

Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today ↗

October 31, 2025

Via Benzinga

Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗

October 30, 2025

Via Benzinga

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗

October 30, 2025

Via Benzinga

Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports ↗

October 30, 2025

Via Investor's Business Daily

Here's How Much $1000 Invested In Insmed 5 Years Ago Would Be Worth Today ↗

October 23, 2025

Via Benzinga

This Is What Whales Are Betting On Insmed ↗

October 15, 2025

Via Benzinga

Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today ↗

October 07, 2025

Via Benzinga

6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner ↗

September 30, 2025

Via Benzinga

Frequently Asked Questions

Is Insmed Incorporated - Common Stock publicly traded?

Yes, Insmed Incorporated - Common Stock is publicly traded.

What exchange does Insmed Incorporated - Common Stock trade on?

Insmed Incorporated - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Insmed Incorporated - Common Stock?

The ticker symbol for Insmed Incorporated - Common Stock is INSM on the Nasdaq Stock Market

What is the current price of Insmed Incorporated - Common Stock?

The current price of Insmed Incorporated - Common Stock is 178.20

When was Insmed Incorporated - Common Stock last traded?

The last trade of Insmed Incorporated - Common Stock was at 12/26/25 11:24 AM ET

What is the market capitalization of Insmed Incorporated - Common Stock?

The market capitalization of Insmed Incorporated - Common Stock is 20.54B

How many shares of Insmed Incorporated - Common Stock are outstanding?

Insmed Incorporated - Common Stock has 21B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.